These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 37991844)

  • 1. Design and Synthesis of Novel Cereblon Binders for Use in Targeted Protein Degradation.
    Norris S; Ba X; Rhodes J; Huang D; Khambatta G; Buenviaje J; Nayak S; Meiring J; Reiss S; Xu S; Shi L; Whitefield B; Alexander M; Horn EJ; Correa M; Tehrani L; Hansen JD; Papa P; Mortensen DS
    J Med Chem; 2023 Dec; 66(23):16388-16409. PubMed ID: 37991844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in Neosubstrate Degradation by Cereblon-Based Molecular Glues and the Development of Novel Multiparameter Optimization Scores.
    Szewczyk SM; Verma I; Edwards JT; Weiss DR; Chekler ELP
    J Med Chem; 2024 Jan; 67(2):1327-1335. PubMed ID: 38170610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On Ternary Complex Stability in Protein Degradation: In Silico Molecular Glue Binding Affinity Calculations.
    Weiss DR; Bortolato A; Sun Y; Cai X; Lai C; Guo S; Shi L; Shanmugasundaram V
    J Chem Inf Model; 2023 Apr; 63(8):2382-2392. PubMed ID: 37037192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel cereblon modulator recruits GSPT1 to the CRL4(CRBN) ubiquitin ligase.
    Matyskiela ME; Lu G; Ito T; Pagarigan B; Lu CC; Miller K; Fang W; Wang NY; Nguyen D; Houston J; Carmel G; Tran T; Riley M; Nosaka L; Lander GC; Gaidarova S; Xu S; Ruchelman AL; Handa H; Carmichael J; Daniel TO; Cathers BE; Lopez-Girona A; Chamberlain PP
    Nature; 2016 Jul; 535(7611):252-7. PubMed ID: 27338790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting cereblon in hematologic malignancies.
    Fuchs O
    Blood Rev; 2023 Jan; 57():100994. PubMed ID: 35933246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunomodulatory agents lenalidomide and pomalidomide co-stimulate T cells by inducing degradation of T cell repressors Ikaros and Aiolos via modulation of the E3 ubiquitin ligase complex CRL4(CRBN.).
    Gandhi AK; Kang J; Havens CG; Conklin T; Ning Y; Wu L; Ito T; Ando H; Waldman MF; Thakurta A; Klippel A; Handa H; Daniel TO; Schafer PH; Chopra R
    Br J Haematol; 2014 Mar; 164(6):811-21. PubMed ID: 24328678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploiting ubiquitin ligase cereblon as a target for small-molecule compounds in medicine and chemical biology.
    Ito T; Yamaguchi Y; Handa H
    Cell Chem Biol; 2021 Jul; 28(7):987-999. PubMed ID: 34033753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profiling CELMoD-Mediated Degradation of Cereblon Neosubstrates.
    Thompson JW; Clayton T; Khambatta G; Bateman LA; Carroll CW; Chamberlain PP; Matyskiela ME
    Methods Mol Biol; 2021; 2365():283-300. PubMed ID: 34432250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cereblon modulators: Low molecular weight inducers of protein degradation.
    Chamberlain PP; Cathers BE
    Drug Discov Today Technol; 2019 Apr; 31():29-34. PubMed ID: 31200856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homo-PROTACs for the Chemical Knockdown of Cereblon.
    Steinebach C; Lindner S; Udeshi ND; Mani DC; Kehm H; Köpff S; Carr SA; Gütschow M; Krönke J
    ACS Chem Biol; 2018 Sep; 13(9):2771-2782. PubMed ID: 30118587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leveraging Ligand Affinity and Properties: Discovery of Novel Benzamide-Type Cereblon Binders for the Design of PROTACs.
    Steinebach C; Bricelj A; Murgai A; Sosič I; Bischof L; Ng YLD; Heim C; Maiwald S; Proj M; Voget R; Feller F; Košmrlj J; Sapozhnikova V; Schmidt A; Zuleeg MR; Lemnitzer P; Mertins P; Hansen FK; Gütschow M; Krönke J; Hartmann MD
    J Med Chem; 2023 Nov; 66(21):14513-14543. PubMed ID: 37902300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential Analysis of Cereblon Neosubstrates in Rabbit Embryos Using Targeted Proteomics.
    Federspiel JD; Catlin NR; Nowland WS; Stethem CM; Mathialagan N; Fernandez Ocaña M; Bowman CJ
    Mol Cell Proteomics; 2024 Jul; 23(7):100797. PubMed ID: 38866076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positive selection of cereblon modified function including its E3 ubiquitin ligase activity and binding efficiency with AMPK.
    Onodera W; Asahi T; Sawamura N
    Mol Phylogenet Evol; 2019 Jun; 135():78-85. PubMed ID: 30836149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of Phenyl-substituted Isoindolinone- and Benzimidazole-type Cereblon Ligands for Targeted Protein Degradation.
    Nie X; Zhao Y; Tang H; Zhang Z; Liao J; Almodovar-Rivera CM; Sundaresan R; Xie H; Guo L; Wang B; Guan H; Xing Y; Tang W
    Chembiochem; 2024 Feb; 25(4):e202300685. PubMed ID: 38116854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ligand-mediated protein degradation reveals functional conservation among sequence variants of the CUL4-type E3 ligase substrate receptor cereblon.
    Akuffo AA; Alontaga AY; Metcalf R; Beatty MS; Becker A; McDaniel JM; Hesterberg RS; Goodheart WE; Gunawan S; Ayaz M; Yang Y; Karim MR; Orobello ME; Daniel K; Guida W; Yoder JA; Rajadhyaksha AM; Schönbrunn E; Lawrence HR; Lawrence NJ; Epling-Burnette PK
    J Biol Chem; 2018 Apr; 293(16):6187-6200. PubMed ID: 29449372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel effect of thalidomide and its analogs: suppression of cereblon ubiquitination enhances ubiquitin ligase function.
    Liu Y; Huang X; He X; Zhou Y; Jiang X; Chen-Kiang S; Jaffrey SR; Xu G
    FASEB J; 2015 Dec; 29(12):4829-39. PubMed ID: 26231201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct-to-biology, automated, nano-scale synthesis, and phenotypic screening-enabled E3 ligase modulator discovery.
    Wang Z; Shaabani S; Gao X; Ng YLD; Sapozhnikova V; Mertins P; Krönke J; Dömling A
    Nat Commun; 2023 Dec; 14(1):8437. PubMed ID: 38114468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defining the human C2H2 zinc finger degrome targeted by thalidomide analogs through CRBN.
    Sievers QL; Petzold G; Bunker RD; Renneville A; Słabicki M; Liddicoat BJ; Abdulrahman W; Mikkelsen T; Ebert BL; Thomä NH
    Science; 2018 Nov; 362(6414):. PubMed ID: 30385546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and biological evaluation of novel quinazolinone derivatives as CRBN E3 ligase modulators.
    Liu L; Sun R; Liu H; Ren C; Zhou Y; Qiu X; Kong Y; Jiang B; Yang X
    Eur J Med Chem; 2023 Feb; 247():115016. PubMed ID: 36577219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. USP15 antagonizes CRL4
    Nguyen TV
    Proc Natl Acad Sci U S A; 2021 Oct; 118(40):. PubMed ID: 34583995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.